Evidence map›Paper›PMID 31366366›Full record

ArticleVirology journal2019

Evaluation of the virucidal effects of rosmarinic acid against enterovirus 71 infection via in vitro and in vivo study.

Wen-Yu Lin, Yu-Jen Yu, Tzyy-Rong Jinn

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Virology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Antiviral Activity and Underlying Mechanism ofMolecules (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. (Revista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia · 2023
    Article
  10. Antiviral Properties ofPathogens (Basel, Switzerland) · 2022
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wen-Yu LinSchool of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan, Republic of China.
Yu-Jen YuSchool of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan, Republic of China.
Tzyy-Rong JinnSchool of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan, Republic of China. jinn@mail.cmu.edu.tw.ORCID 0000-0001-7176-4807
China Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough enterovirus 71 (EV71) is an important public health threat, especially in the Asia-Pacific region, there are still no effective drugs or vaccines to treat and prevent EV71 infection. Therefore, it is critical to develop prophylactic and therapeutic agents against EV71. Rosmarinic acid (RA), a phytochemical, has been discovered to possess a broad spectrum of biological activities.

methodsThe virucidal effects of RA on EV71 were determined by MTT, western blot, median cell culture infectious dose, apoptosis detection, plaque reduction, semi-quantitative real-time polymerase chain reaction, immunofluorescence detection, molecular docking analysis, and mouse protection assay.

resultsRA showed a strong protective effect against EV71 infection in human rhabdomyosarcoma cells when the multiplicity of infection was 1, with a low IC

conclusionsThis study suggests that RA has the potential to be developed as an antiviral agent against initial EV71 infection to prevent or reduce EV71-induced pathogenesis and complications, since RA can effectively reduce EV71 infection in the early stages of viral infection.

Indexed as

AnimalsAnimals, NewbornAntiviral AgentsCell Line, TumorCinnamatesCytopathogenic Effect, ViralDepsidesEnterovirus A, HumanEnterovirus InfectionsHumansInhibitory Concentration 50MiceMolecular Docking SimulationRosmarinic AcidVirus ReplicationAntiviral AgentsCinnamatesDepsidesRosmarinic AcidEnterovirus 71Herbal medicineMolecular dockingNeonatal miceRosmarinic acidVirucidal efficacy

Identifiers

PMID31366366
PMCPMC6670152
OpenAlexW2966018070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.